JMS-17-2

Ask supplier a question | View on supplier's website

JMS-17-2 is a potent and selective small-molecule antagonist of CX3C chemokine receptor 1 (CX3CR1/GPR13) with IC50 of 0.32 nM. JMS-17-2 is used in the research of metastatic disease in breast cancer patients.

Supplier	Selleck Chemicals
Product #	S0135
Sku #	S0135-5mg
Pricing	5mg, $177.00

Feedback